A combination phase I trial of peptide vaccines and Docetaxel/5'-DFUR in patients with advanced or recurrent gastric cancer
Phase 1
- Conditions
- Advanced or recurrent gastric cancer
- Registration Number
- JPRN-UMIN000009751
- Lead Sponsor
- Yamaguchi University Graduate School of Medicine, Digestive surgery and surgical oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Serious infectious disease or other severe complications (e.g. pulmonary fibrosis / interstitial pneumonia, uncontrollable diabetes); pregnancy or lactation, or trying to get pregnant; a history of drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Immunological effect Objective responses Overall survival